filmov
tv
2- How to Critically Appraise a Randomised Controlled Trial following the CASP checklist: Question 2

Показать описание
Barts Health Knowledge and Library Services’ Adam Tocock goes through Question 2 of the CASP RCT Checklist, “Was the assignment of participants to interventions randomised?” in relation to the following paper:
Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis. J Pain Res. 2018 Apr 18;11:809-821. doi: 10.2147/JPR.S164128. PMID: 29713194; PMCID: PMC5912377.
Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis. J Pain Res. 2018 Apr 18;11:809-821. doi: 10.2147/JPR.S164128. PMID: 29713194; PMCID: PMC5912377.